Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems

Statistics in Medicine

Volumn 21, Issue 19, 2002, Pages 2917-2930

  Pocock, Stuart J ^a   Assmann, Susan E ^b   Enos, Laura E ^b   Kasten, Linda E ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

Baseline comparisons; Clinical trials; Covariate adjustment; Medical journals; Subgroup analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; HEART FAILURE; HEART INFARCTION; HUMAN; MEDICAL LITERATURE; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE; RANDOMIZATION; STATISTICAL ANALYSIS; STATISTICS; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERIODICALS; PUBLICATIONS; RANDOMIZED CONTROLLED TRIALS; SOCIAL SUPPORT;

EID: 0037108235     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1296     Document Type: Article

References (28)

1. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355:1064-1069.
2. Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomised clinical trials. Journal of the American Medical Association 1991; 266:93-98.
3. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials: a survey of three medical journals. New Enyland Journal of Medicine 1987; 317:426-432.
4. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 1985; 41:361-372.
5. Dixon DO, Simon R. Bayesian subset analysis. Biometrics 1991; 47:871-882.
6. Simon R. Bayesian subset analysis: application to studying treatment-by-gender interactions. Statistics in Medicine (in press).
7. Frasure-Smith N, Lespérance F, Prince RH, Verrier P, Garber R, Juneau M, Wolfson C, Bourassa M. Randomised trial of home-based psychological nursing intervention for patients recovering from myocardial infarction. Lancet 1997; 350:473-479.
8. Kostis JB, David BR, Cutler J, Grimm RH, Berge KG, Cohen JD, Lacy CR, Perry HM, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, McFate Smith W, McDonald R, Applegate WB. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. Journal of the American Medical Association 1997; 278:212-216.
9. Altman DG. Adjustment for covariate imbalance. In Encyclopaedia of Biostatistics, Armitage P, Colton T (eds). Wiley: Chichester, 1998; 1000-1005.
10. Raab GM, Day S, Sales J. How to select covariates to include in the analysis of a clinical trial. Controlled Clinical Trials 2000; 21:330-342.
11. Senn SJ. Covariate imbalance and random allocation in clinical trials. Statistics in Medicine 1989; 8:467-475.
12. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Statistics in Medicine 1992; 2:1685-1704.
13. Snedecor GW, Cochran WG. Analysis of covariance. In Statistical Methods. Iowa State University Press: Ames, 1989; 419-446.
14. Robinson LD, Jewell NP. Some surprising results about covariate adjustment in logistic regression models. International Statistical Review 1991; 59:227-240.
15. Ford I, Norrie J, Ahmadi S. Model inconsistency, illustrated by the Cox proportional hazards model. Statistics in Medicine 1995; 14:735-746.
16. Ford I, Norrie J. The role of covariates in estimating treatment effects and risk in long-term clinical trials. Statistics in Medicine.
17. Schluchter MD, Forsythe AB. Post-hoc selection of covariates in randormsed experiments. Communications in Statistics - Theory and Methods 1985; 14:679-699.
18. Beach ML, Meier P. Choosing covariates in the analysis of clinical trials. Controlled Clinical Trials 1989; 10:161S-175S.
19. Van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE. The National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. New England Journal of Medicine 1997; 337:15-21.
20. Olds DL, Eckenrode J, Henderson CR, Kitzman H, Powers J, Cole R, Sidora K, Morris P, Pettitt LM, Luckey D. Long-term effects of home visitation on maternal life course and child abuse and neglect. Journal of the American Medical Association 1997; 278:637-643.
21. Rolfs RT, Riduan Joesoef M, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, Bolan G, Johnson SC, French P, Steen E, Radolf JD, Larsen S. A randomised trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. New England Journal of Medicine 1997; 337:307-314.
22. Sundberg K, Bank J, Smidt-Jensen S, Brocks V, Lundsteen C, Parner J, Keiding N, Philip J. Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling. Lancet 1997; 350:697-703.
23. Senn S. Testing for baseline balance in clinical trials. Statistics in Medicine 1994; 13:1715-1726.
24. Altman DG. Comparability of randomised groups. Statistician 1985; 34:125-136.
25. Gordin FM, Matts JP, Miller C, Brown LS, Hafner R, John SL, Klein M, Vaughn A, Besch CL, Perez G, Szabo S, El-Sadr W. A controlled trial of isoniazid in persons with energy and human immunodeficiency virus infection who are at high risk for tuberculosis. New England Journal of Medicine 1997; 337:315-320.
26. Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. New England Journal of Medicine 1997; 337:657-662.
27. Moher D, Schutz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357:1191-1194.
28. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gotzsche PC, Lang T. The revised CONSORT statement for reporting randomised trials: explanation and elaboration. Annals of Internal Medicine 2001; 134:663-694.